Related references
Note: Only part of the references are listed.The ARIC (Atherosclerosis Risk In Communities) Study JACC Focus Seminar 3/8
Jacqueline D. Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
Michael S. Sabbah et al.
CIRCULATION-HEART FAILURE (2020)
Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study
David Aguilar et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Sex differences in heart failure
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2019)
Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance
Patricia P. Chang et al.
CIRCULATION (2018)
Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction
Uzair Ansari et al.
ANNALS OF LABORATORY MEDICINE (2018)
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Anahita Ghorbani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
Sheryl L. Chow et al.
CIRCULATION (2017)
Obesity and Subtypes of Incident Cardiovascular Disease
Chiadi E. Ndumele et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality
Christina M. Parrinello et al.
AMERICAN HEART JOURNAL (2015)
Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Clinical use of novel biomarkers in heart failure: towards personalized medicine
Daniela Schmitter et al.
HEART FAILURE REVIEWS (2014)
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Cynthia L. Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Mechanisms of heart failure in obesity
Imo A. Ebong et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2014)
Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management
Martin A. Alpert et al.
TRANSLATIONAL RESEARCH (2014)
Best Practices and Joint Calling of the HumanExome BeadChip: The CHARGE Consortium
Megan L. Grove et al.
PLOS ONE (2013)
A New Equation to Estimate Glomerular Filtration Rate in Chinese Elderly Population
Xun Liu et al.
PLOS ONE (2013)
Galectin-3 and the Development of Heart Failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22
E. Wilson Grandin et al.
CLINICAL CHEMISTRY (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Genome-Wide Association Study of Circulating Galectin-3
Rudolf A. de Boer et al.
PLOS ONE (2012)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
Ravi V. Shah et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Galectin-3: a novel mediator of heart failure development and progression
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Adiposity of the heart*, revisited
JM McGavock et al.
ANNALS OF INTERNAL MEDICINE (2006)
Obesity and the risk of heart failure
S Kenchaiah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
